Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple Sclerosis

Conclusion: Rise in the serum VEGF level may be involved in MS ’s relapsing phases and a shorter remission phase. Therefore, it could be used as a prognostic and predictive biomarker for MS disease.Neuroimmunomodulation
Source: Neuroimmunomodulation - Category: Allergy & Immunology Source Type: research